Varsity to host free Cancer screening this February
The University is gearing up for a cancer screening session on 6th February at the main campus to enable community members including students know their health status, given the rise of cancer in developing Nations, and the world.
In this year’s free screening that falls under the Varsity’s CSR health programme, tests will be done by the Cancer Awareness Centre Kenya (CACK) in collaboration with Lions Club -Ruiru Chapter and the Zetech Leo Club, and will provide a resourced set up for the full day campaign.
According to CACK, the cancer burden is rising globally, exerting significant strain on populations and health systems at all income levels. In Kenya, cancer is the 3rd leading cause of death after infectious and cardiovascular diseases. The Centre further quoted that for 2018, the International Agency for Research in Cancer (IARC) GLOBOCAN reported estimated 47,887 new cases of cancer annually with a mortality of 32,987.
In the initiative, students, staff and members of the community will benefit from free health advice and access tests for breast, prostate and cervical cancer at the stationed location within Ruiru.
VC Prof Njenga Munene noted that the initiative is a great move in addressing the community’s health needs while implementing the University’s role in empowering the community through available resources.
Timothy Wangwe, the Chairperson of the recently Zetech Leo Club appreciated the University for engaging various partners to ensure free screening is availed to as many people as possible.
In the battle against the killer disease, Prevention and Control centres estimate that between 2010 and 2020, the number of new cancer cases in the world will go up with Australia recorded to have the highest cancer rate in the world, with about 468 cases per 100,000 people.
In East Africa, Kenya tops Uganda and Tanzania in cancer deaths; Cancer kills 32,987 Kenyans a year, an estimated 40 per cent of the 83,426 deaths reported in the three EA countries according to the WHO’s Globocan report that analyses new cases among men and women.